# Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan

> **NCT01311362** · — · COMPLETED · sponsor: **Gerd Mikus** · enrollment: 20 (actual)

## Conditions studied

- Drug Interactions

## Interventions

- **DRUG:** St. Johns wort

## Key facts

- **NCT ID:** NCT01311362
- **Lead sponsor:** Gerd Mikus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311362, "Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01311362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*